MiNK Therapeutics, Inc.INKTNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank60
3Y CAGR-51.0%
5Y CAGR+72.6%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
-51.0%/yr
Annual compound
5Y CAGR
+72.6%/yr
Recent deceleration
Percentile
P60
Within normal range
vs 5Y Ago
15.3x
Strong expansion
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
2024$4.58M+35.9%
2023$3.37M-82.9%
2022$19.64M-49.5%
2021$38.89M+1345.1%
2020$2.69M+799.9%
2019$299036.00-